000 01353 a2200373 4500
005 20250511190643.0
264 0 _c19920922
008 199209s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.36.5.926
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKageyama, S
245 0 0 _aIn vitro inhibition of human immunodeficiency virus (HIV) type 1 replication by C2 symmetry-based HIV protease inhibitors as single agents or in combinations.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cMay 1992
300 _a926-33 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aDidanosine
_xpharmacology
650 0 4 _aDrug Interactions
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHIV Protease Inhibitors
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aVirus Replication
_xdrug effects
650 0 4 _aZidovudine
_xpharmacology
700 1 _aWeinstein, J N
700 1 _aShirasaka, T
700 1 _aKempf, D J
700 1 _aNorbeck, D W
700 1 _aPlattner, J J
700 1 _aErickson, J
700 1 _aMitsuya, H
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 36
_gno. 5
_gp. 926-33
856 4 0 _uhttps://doi.org/10.1128/AAC.36.5.926
_zAvailable from publisher's website
999 _c1516898
_d1516898